Universidad Peruana Cayetano Heredia

Nested case-control study of the emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae

Mostrar el registro sencillo del ítem

dc.contributor.author Nigo, Masayuki
dc.contributor.author Cevallos, Catalina Salinas
dc.contributor.author Woods, Krystina
dc.contributor.author Flores, Vicente Maco
dc.contributor.author Francis, Gweneth
dc.contributor.author Perlman, David C.
dc.contributor.author Revuelta, Manuel
dc.contributor.author Mildvan, Donna
dc.contributor.author Waldron, Mary
dc.contributor.author Gomez, Tessa
dc.contributor.author Koshy, Sanjana
dc.contributor.author Jodlowski, Tomasz
dc.contributor.author Riley, William
dc.contributor.author Ruhe, Jorg J.
dc.date.accessioned 2022-01-04T20:29:54Z
dc.date.available 2022-01-04T20:29:54Z
dc.date.issued 2013
dc.identifier.uri https://hdl.handle.net/20.500.12866/10377
dc.description.abstract We performed a nested case-control study (ratio of 1:4) on the emergence of tigecycline-resistant multidrug-resistant Klebsiella pneumoniae (TR-MDRKP) isolates among patients who initially presented with a tigecycline-susceptible MDRKP isolate. Out of 260 patients, 24 (9%) had a subsequent clinical culture positive for a TR-MDRKP isolate within the 90-day follow-up period. On logistic regression analyses, receipt of tigecycline (adjusted odds ratio [OR], 5.06; 95% confidence interval [CI], 1.80 to 14.23; P = 0.002) was the only independent predictor of subsequent isolation of a TR strain. en_US
dc.language.iso eng
dc.publisher American Society for Microbiology
dc.relation.ispartofseries Antimicrobial Agents and Chemotherapy
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject human en_US
dc.subject controlled study en_US
dc.subject bacterium culture en_US
dc.subject case control study en_US
dc.subject Aged, 80 and over en_US
dc.subject Time Factors en_US
dc.subject bacterial strain en_US
dc.subject Microbial Sensitivity Tests en_US
dc.subject Anti-Bacterial Agents en_US
dc.subject antibiotic therapy en_US
dc.subject clinical article en_US
dc.subject follow up en_US
dc.subject Follow-Up Studies en_US
dc.subject drug exposure en_US
dc.subject Logistic Models en_US
dc.subject drug treatment failure en_US
dc.subject Drug Resistance, Multiple, Bacterial en_US
dc.subject bacterium isolate en_US
dc.subject aminoglycoside en_US
dc.subject quinolone derivative en_US
dc.subject monotherapy en_US
dc.subject antibiotic resistance en_US
dc.subject cephalosporin en_US
dc.subject Klebsiella pneumoniae en_US
dc.subject tigecycline en_US
dc.subject vancomycin en_US
dc.subject clindamycin en_US
dc.subject urinary tract infection en_US
dc.subject molecular typing en_US
dc.subject aztreonam en_US
dc.subject carbapenem en_US
dc.subject Charlson Comorbidity Index en_US
dc.subject Klebsiella Infections en_US
dc.subject linezolid en_US
dc.subject metronidazole en_US
dc.subject Minocycline en_US
dc.subject multidrug resistant Klebsiella pneumoniae en_US
dc.subject polymyxin en_US
dc.title Nested case-control study of the emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae en_US
dc.type info:eu-repo/semantics/article
dc.identifier.doi https://doi.org/10.1128/AAC.00827-13
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.02.21
dc.relation.issn 1098-6596


Ficheros en el ítem

Ficheros Tamaño Formato Ver

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

info:eu-repo/semantics/restrictedAccess Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/restrictedAccess

Buscar en el Repositorio


Listar

Panel de Control

Estadísticas